Sphenopalatine Ganglion Block for Post-Dural Puncture Headache
| Status: | Withdrawn |
|---|---|
| Conditions: | Migraine Headaches, Orthopedic |
| Therapuetic Areas: | Neurology, Orthopedics / Podiatry |
| Healthy: | No |
| Age Range: | 18 - 45 |
| Updated: | 11/10/2017 |
| Start Date: | November 2014 |
| End Date: | December 31, 2016 |
Sphenopalatine Ganglion Block for Treatment of Postdural Puncture Headache: A Prospective Randomized Double Blind Placebo Controlled Study
The investigators are attempting to determine a less invasive method of treatment for
postdural puncture headaches that can occur after regional anesthesia. The investigators will
be evaluating the relief of headache with those subjects receiving treatment with a
sphenopalatine ganglion block with bupivacaine versus placebo, evaluating the incidence of
epidural blood patch, pain score of headache at 1 hour, then 24, 48, and 72 hours lower with
post study treatment versus placebo, and potential side effects of those patients receiving
study therapy as well as epidural blood patch.
postdural puncture headaches that can occur after regional anesthesia. The investigators will
be evaluating the relief of headache with those subjects receiving treatment with a
sphenopalatine ganglion block with bupivacaine versus placebo, evaluating the incidence of
epidural blood patch, pain score of headache at 1 hour, then 24, 48, and 72 hours lower with
post study treatment versus placebo, and potential side effects of those patients receiving
study therapy as well as epidural blood patch.
Inclusion Criteria:
- American Society of Anesthesiologists assigned class I-III
- age >/= 18 years
- experiencing a postdural puncture headache within 7 days of neuraxial analgesia rated
>3/10 pain score
Exclusion Criteria:
- allergy to study medications <18 years of age pain score on presentation headache
We found this trial at
1
site
Click here to add this to my saved trials
